Caliper easily beat analysts' consensus estimate, which was expected after the firm pre-announced Q4 revenues in January. Its IVIS imaging products were the key driver of revenue growth for the quarter.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.